Company / Current Liabilities
Ginkgo Bioworks Holdings, Inc. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$96.0M
FY2025
5-year range
$96.0M / $173.0M
FY2021-FY2025
Trend
-10.5%
vs FY2024
Sector context
#99 of 215
Health Care
What the data says
At $96M, Ginkgo Bioworks Holdings, Inc.'s current liabilities ranks #117 of 215 in the Health Care sector. Current Liabilities has declined for 3 consecutive years, from $173M in FY2022 to $96M in FY2025.
Based on SEC 10-K filings.
$96M in FY2025 with a 5-year CAGR of +5.6%.
Improved from $164M to $96M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -17.8%
- 5-Year CAGR
- +5.6%
- 10-Year CAGR
- -
Sector benchmark
#117 of 215 in Health CareTop 54% of 215This company $96.0M Sector average $1.6B
▼
-93.9% below sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s current liabilities has declined for 3 consecutive years.
- 5-year CAGR of +5.6%, indicating consistent growth.
- In FY2025, current liabilities decreased 10.5% year-over-year.
- Ranks #99 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $96.0M | -10.5% |
| FY2024 | $107.3M | -34.5% |
| FY2023 | $163.9M | -5.3% |
| FY2022 | $173.0M | +28.3% |
| FY2021 | $134.8M | +84.0% |
| FY2020 | $73.2M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026